Cinctive Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,000
Closed -$8.11M 550
2022
Q2
$8.11M Buy
25,000
+15,000
+150% +$4.5M 0.34% 91
2022
Q1
$2.86M Buy
+10,000
New +$2.57M 0.11% 276

Other funds holding LLY

Cinctive Capital Management's LLY Position: Q1 2026 in Review

Cinctive Capital Management increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $266K and bringing the position to 10,008 shares worth $9.21M. The position accounts for 0.6% of the portfolio, ranked #43.

Cinctive Capital Management first reported a position in LLY in Q3 2020 and has held it in 11 quarters since. The position peaked at $12.8M in Q3 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cinctive Capital Management held 10,008 shares of Eli Lilly worth $9.21M as of Q1 2026.
  • Cinctive Capital Management bought 262 Eli Lilly shares in Q1 2026, an estimated $266K.
  • Eli Lilly made up 0.6% of Cinctive Capital Management's portfolio in Q1 2026, its #43 holding.
  • Cinctive Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 11 quarters since.
  • Cinctive Capital Management's Eli Lilly position peaked at $12.8M in Q3 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.